The almost year-long saga involving defective hip implants continues unabated as a U.S. Senate Special Committee on Aging will soon hear testimony related to the issue. According to Mass Device, the hearing will come as part of a bigger investigation into the patient safety approval process currently available for medical devices. As the DePuy hip recall made clear, many questions remain about the safety of devices rushed to market and given to unsuspecting medical patients.
Reports indicate today’s testimony will place the Johnson & Johnson company in the middle of the federal investigation evaluating that medical device approval process. After representatives from the large medical company testify, the committee will then hear from one of the victims of the recall-many Illinois medical patients found themselves in a similar circumstance to the victim who will speak to the committee.
In addition, a national researcher will explain data that indicates that there are more recalls of devices that are approved through the 510(k) pre-market notification program. This alternative approval process allows devices to reach consumers sooner without the stringent testing required by the Food and Drug Administration’s more comprehensive PMA protocol.
The subcommittee holding the hearing explained, “Internal reviews by FDA officials and other outside sources have found troubling lapses in the procedures by which a number of medical devices were approved. The results of these investigations caused procedural and management changes to be implemented at the Center for Devices and Radiological Health in recent months.”
Our Chicago DePuy hip recall attorneys at Levin & Perconti well understand the immense cost that these defective devices have on suffering victims. The risk of revision surgery, complications from the defective products, and stressful toll taken on the patient are unacceptable. It is vital that no future defective devices be allowed to easily harm so many community members. We hope that DePuy hip recall lawsuits help send the message that patient care and safety must be a priority for these large medical companies.
See Our Related Blog Posts: